Literature DB >> 9596672

Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10.

J A Hedrick1, A Helms, A Vicari, A Zlotnik.   

Abstract

We have identified and characterized a human beta (CC) chemokine, designated HCC-4, that is most closely related to HCC-1 and which demonstrates chemotactic activity for monocytes. Northern analysis of multiple tissue blots and of activated monocytes mRNA shows expression of a 500-bp mRNA. A 1,500-bp mRNA was highly expressed in monocytes activated 12 hours in the presence of interleukin-10 (IL-10) but was absent in monocytes activated for only 1 hour regardless of the presence or absence of IL-10. The upregulation of expression in the presence of IL-10 is in contrast to the downregulatory effects of IL-10 on expression of most other chemokines. Recombinant HCC-4 demonstrated chemotactic activity for human monocytes and THP-1 monocyte cells but not for resting lymphocytes or neutrophils. HCC-4 also induced a Ca2+ flux in THP-1 cells that was desensitized by prior exposure to RANTES. Taken together, these data indicate that HCC-4 is a novel chemokine whose expression is uniquely upregulated by IL-10.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596672

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study.

Authors:  A Y Del Valle-Pinero; A C Martino; T J Taylor; B L Majors; N S Patel; M M Heitkemper; W A Henderson
Journal:  Neurogastroenterol Motil       Date:  2011-09-23       Impact factor: 3.598

2.  IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours.

Authors:  L-X Wang; F Talebian; J-Q Liu; M Khattabi; L Yu; X-F Bai
Journal:  Scand J Immunol       Date:  2012-03       Impact factor: 3.487

3.  The treatment efficacy of nasal polyposis on olfactory functions, clinical scoring systems and inflammation markers.

Authors:  Zehra Betul Paksoy; Melih Cayonu; Cigdem Yucel; Turan Turhan
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-31       Impact factor: 2.503

4.  CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells.

Authors:  J Morales; B Homey; A P Vicari; S Hudak; E Oldham; J Hedrick; R Orozco; N G Copeland; N A Jenkins; L M McEvoy; A Zlotnik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

5.  Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis.

Authors:  Jiaxiang Ji; Jiaren Sun; Lynn Soong
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 6.  Chemokines as molecular targets for therapeutic intervention.

Authors:  O M Howard; J J Oppenheim; J M Wang
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

7.  CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.

Authors:  Wenzhi Shen; Xiaoyuan Zhang; Jiaping Tang; Zhixin Zhang; Renle Du; Dehong Luo; Xiaoran Liu; Yong Xia; Yanping Li; Shanshan Wang; Siyuan Yan; Wancai Yang; Rong Xiang; Na Luo; Yunping Luo; Jianjun Li
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 8.  Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease.

Authors:  Shaoping She; Liying Ren; Pu Chen; Mingyang Wang; Dongbo Chen; Ying Wang; Hongsong Chen
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

9.  Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis.

Authors:  Ashwini L Chand; Andrew S Murray; Rebecca L Jones; Natalie J Hannan; Lois A Salamonsen; Luk Rombauts
Journal:  Reprod Biol Endocrinol       Date:  2007-05-17       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.